
    
      PROTOCOL OUTLINE: Patients are stratified by gestational age and sex, and randomly assigned
      in pairs per stratum.

      One group receives a preventive dose of tin mesoporphyrin. Another group receives a
      therapeutic dose of tin mesoporphyrin according to the plasma bilirubin concentration.

      Patients in either group may be treated concurrently with phototherapy or exchange
      transfusion if clinically indicated.
    
  